The role of optical coherence tomography in anti-vascular endothelial growth factor therapies

Anne Fung; Nikolas London; Philip Rosenfeld

doi:10.1007/978-0-387-68987-6_15

The role of optical coherence tomography in anti-vascular endothelial growth factor therapies

Anne Fung, Nikolas London, Philip Rosenfeld

Ophthalmology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Vascular endothelial growth factor (VEGF) has emerged as a key mediator of angiogenesis and macular edema in ocular diseases such as neovascular macular degeneration, vein occlusions, and diabetic retinopathy.^1,2 Therapies to neutralize VEGFs action in ocular diseases have been used to successfully combat VEGFs pathogenic role in the eye.

Original language	English (US)
Title of host publication	Retinal Angiography and Optical Coherence Tomography
Publisher	Springer New York
Pages	279-288
Number of pages	10
ISBN (Print)	9780387689869
DOIs	https://doi.org/10.1007/978-0-387-68987-6_15
State	Published - Dec 1 2009

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1007/978-0-387-68987-6_15

Fingerprint Dive into the research topics of 'The role of optical coherence tomography in anti-vascular endothelial growth factor therapies'. Together they form a unique fingerprint.

Cite this

Fung, A., London, N., & Rosenfeld, P. (2009). The role of optical coherence tomography in anti-vascular endothelial growth factor therapies. In Retinal Angiography and Optical Coherence Tomography (pp. 279-288). Springer New York. https://doi.org/10.1007/978-0-387-68987-6_15

@inbook{40d05ee296694a24862c5681ce793acf,

title = "The role of optical coherence tomography in anti-vascular endothelial growth factor therapies",

abstract = "Vascular endothelial growth factor (VEGF) has emerged as a key mediator of angiogenesis and macular edema in ocular diseases such as neovascular macular degeneration, vein occlusions, and diabetic retinopathy.1,2 Therapies to neutralize VEGFs action in ocular diseases have been used to successfully combat VEGFs pathogenic role in the eye.",

author = "Anne Fung and Nikolas London and Philip Rosenfeld",

year = "2009",

month = dec,

day = "1",

doi = "10.1007/978-0-387-68987-6_15",

language = "English (US)",

isbn = "9780387689869",

pages = "279--288",

booktitle = "Retinal Angiography and Optical Coherence Tomography",

publisher = "Springer New York",

}

TY - CHAP

T1 - The role of optical coherence tomography in anti-vascular endothelial growth factor therapies

AU - Fung, Anne

AU - London, Nikolas

AU - Rosenfeld, Philip

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Vascular endothelial growth factor (VEGF) has emerged as a key mediator of angiogenesis and macular edema in ocular diseases such as neovascular macular degeneration, vein occlusions, and diabetic retinopathy.1,2 Therapies to neutralize VEGFs action in ocular diseases have been used to successfully combat VEGFs pathogenic role in the eye.

AB - Vascular endothelial growth factor (VEGF) has emerged as a key mediator of angiogenesis and macular edema in ocular diseases such as neovascular macular degeneration, vein occlusions, and diabetic retinopathy.1,2 Therapies to neutralize VEGFs action in ocular diseases have been used to successfully combat VEGFs pathogenic role in the eye.

UR - http://www.scopus.com/inward/record.url?scp=84892070661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892070661&partnerID=8YFLogxK

U2 - 10.1007/978-0-387-68987-6_15

DO - 10.1007/978-0-387-68987-6_15

M3 - Chapter

AN - SCOPUS:84892070661

SN - 9780387689869

SP - 279

EP - 288

BT - Retinal Angiography and Optical Coherence Tomography

PB - Springer New York

ER -